
10.36 Delayed Data As of Jul 01 | ![]() Today’s Change | 10.08 Today|||52-Week Range 41.39 | -59.52% Year-to-Date |
The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
1 month | -26.59% | 3 years | -- | |
3 months | -50.41% | 5 years | -- | |
1 year | -74.20% | Since inception | -38.22% |
Previous close | $10.35 |
Open day’s range | 10.32 – 10.49 |
Net asset value (NAV) | 10.35 (06/30/2022) |
Daily volume | 465,498 |
Average volume (3 months) | 1,340,864 |
MSOS | Category | |
---|---|---|
Performance 5-yr return | -- | +13.67% |
Expense Gross exp ratio | 0.73% | -- |
Risk 5 year sharpe ratio | -- | -- |
Net assets | $698.1M | -- |
Average market cap | -- | $11.8B |
Average P/E | -- | 22.9 |
Dividend / Share | -- | 0.04% |
No competitors data available. |
Business service | -- |
Consumer goods | -- |
Consumer service | -- |
Energy | -- |
Financial service | -- |
Holdings not available. |